{{Rsnum
|rsid=977102
|Chromosome=3
|position=67323553
|Orientation=plus
|GMAF=0.1217
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 80.4 | 18.8 | 0.9
| HCB | 71.2 | 25.0 | 3.8
| JPT | 74.8 | 20.7 | 4.5
| YRI | 80.4 | 17.5 | 2.1
| ASW | 77.2 | 22.8 | 0.0
| CHB | 71.2 | 25.0 | 3.8
| CHD | 66.7 | 30.5 | 2.9
| GIH | 93.9 | 6.1 | 0.0
| LWK | 76.4 | 23.6 | 0.0
| MEX | 89.5 | 10.5 | 0.0
| MKK | 68.2 | 30.5 | 1.3
| TSI | 62.0 | 34.0 | 4.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}